Brief: Enorama Pharma In Licence Negotiations With Habit Factory

Enorama Pharma AB

12/02/2025 07:43

Feb 12 (Reuters) - Enorama Pharma AB (publ)   ERMA.ST :
    * SAID ON TUESDAY IT HAD INITIATED NEGOTIATIONS ON A LICENCE
AGREEMENT WITH ITS ASSOCIATED COMPANY HABIT FACTORY IN SWEDEN AB
    * ENORAMA MAY GRANT HABIT FACTORY A RIGHT TO USE ENORAMA
PHARMA'S
INTELLECTUAL PROPERTY FOR THE PRODUCTION OF NICOTINE PRODUCTS IN
RETURN FOR MARKET COMPENSATION
    * IN THE EVENT THE PARTIES ENTER INTO THE LICENCE AGREEMENT,
ENORAMA PHARMA WILL SUBMIT A REQUEST TO THE US FDA TO ALLOW
HABIT FACTORY TO SELL PRODUCTS UNDER ITS OWN BRAND NAME 
    * LICENCE AGREEMENT WILL BE VALID UNTIL 31 DECEMBER 2029 AT
THE
LATEST


        
 Source text for Workspace:  urn:newsml:reuters.com:*:nWkr8gpKXJ
 Further company coverage:  ERMA.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))